N2C-11008-43292
3 vaccinations
4 coded responses
30 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 945 / CA
- Registered
- 2021-08-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-30
Registered in v-safe
-
2021-08-30
Dose 1 — Pfizer-BioNTech
-
2021-08-30
Survey response — day 0, dose 1MedDRA: Heart rate increased — Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to work or attend schoolFree text: INCREASED HEART RATE- 110-120 BPM AT TIMESMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache · Be unable to work or attend schoolAdult check-in
- 2021-09-01
- 2021-09-02
- 2021-09-03
- 2021-09-04
- 2021-09-05
- 2021-09-06
- 2021-09-13
- 2021-09-20
-
2021-09-24
Dose 2 — Pfizer-BioNTech
- 2021-09-27
- 2021-09-28
- 2021-09-29
- 2021-09-30
-
2021-10-01
Survey response — day 7, dose 2MedDRA: Rash — Feeling: GoodFree text: Rash noted on chest yesterday, looks better todayMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-12-24
- 2022-03-27
-
2022-04-15
Dose 3 — Pfizer-BioNTech
- 2022-04-30
- 2022-05-08
- 2022-05-13
- 2022-05-20
- 2022-05-27
- 2022-07-15
-
2022-10-14
Survey response — 6 months, dose 3MedDRA: COVID-19, Illness — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid I'llnessMedDRA releases: 2024-11 · check-in free text available
-
2023-04-17
Survey response — 12 months, dose 3MedDRA: Blood cholesterol increased, Lipids increased, Lymphocyte count increased — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-17
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-30 | Pfizer-BioNTech | No |
| 2 | 2021-09-24 | Pfizer-BioNTech | No |
| 3 | 2022-04-15 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): INCREASED HEART RATE- 110-120 BPM AT TIMES
Release 9 — day 7, dose 2
Systemic reaction (other): Rash noted on chest yesterday, looks better today
Release 12 — 6 months, dose 3
Symptoms: Covid I'llness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood cholesterol increased | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Illness | · | · | ✓ |
| SD | Lipids increased | · | · | ✓ |
| SD | Lymphocyte count increased | · | · | ✓ |
| SRO | Heart rate increased | ✓ | · | ✓ |
| SRO | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release